发明授权
- 专利标题： ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
- 专利标题（中）： ANTI-IGSF4抗体及其用途
-
申请号： EP06714335.4申请日： 2006-02-22
-
公开(公告)号： EP1860119B1公开(公告)日： 2011-08-03
- 发明人: AKAHORI, Yasushi , SUGIOKA, Atsushi, VIEQU COURT DENJIYAMA , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , SUZUKI, Kazuhiro , MORITA, Miwa , KUROSAWA, Yoshikazu , IBA, Yoshitaka , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , TAKAHASHI, Nobuhiro, c/o The Faculty of Agriculture , FUJIYAMA, Sari , AZUMA, Masachika, c/o Inst. Antibodies Co., Ltd , UKAI, Yoshinori, c/o Inst. Antibodies Co., Ltd , MORISHITA, Kazuhiro, Miyazaki Medical College, Dept. of Biochemistry
- 申请人： Institute for Antibodies Co., Ltd. , Kurosawa, Yoshikazu
- 申请人地址： 4-5-3, Sakae Naka-ku Nagoya Aichi 460-0008 JP
- 专利权人： Institute for Antibodies Co., Ltd.,Kurosawa, Yoshikazu
- 当前专利权人： Institute for Antibodies Co., Ltd.,Kurosawa, Yoshikazu
- 当前专利权人地址： 4-5-3, Sakae Naka-ku Nagoya Aichi 460-0008 JP
- 代理机构： Müller Fottner Steinecke
- 优先权： JP2005054624 20050227
- 国际公布： WO2006090750 20060831
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K39/00 ; A61P35/00 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12N15/09 ; C12Q1/02 ; G01N33/15 ; G01N33/50
摘要：
It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, an ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
公开/授权文献
- EP1860119A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME 公开/授权日：2007-11-28
信息查询
